NorthWest Biotherapeutics Inc (NWBO)

[CDRD]

The "INFLECTION POINT" for the company according to Les were 4 things:

1. The end of the trial (i.e. release of topline results)
2. The scientific paper
3. The start of the UCLA trial (which we now see is scheduled)
4. The start of a Germany trial

If I were advising them I would want these events to coalesce into a very short window of time--perhaps even a single PR or presentation (or both) for maximum impact.

Because of their low cash position, these have to happen (IMHO) sooner rather than later. Sooner being within the next few months.

Obviously, I am hoping for good news on all fronts. If so, i could believe a $10B evaluation or about $22 per share---I'll take that!

GLTA